The Delhi-based healthtech aims to expand its footprint and deepen innovation in non-surgical, minimally invasive pain relief as investor interest in chronic care grows.
Healthtech startup Nivaan Care has raised $7 Mn (INR 64.2 Cr) in its Series A round led by Sorin Investments, with participation from W Health Ventures, Endiya Partners, and Rebright Partners. The funding marks a significant milestone for the Delhi-based startup, which offers non-surgical, minimally invasive chronic pain management solutions across India.
The fresh capital will be used to expand its physical clinic network, particularly in cities like Bengaluru, and to advance clinical capabilities and innovation in pain management techniques tailored for Indian patients.
“This capital allows us to scale responsibly—expanding our footprint and innovating on patient-first solutions,” said Nivesh Khandelwal, cofounder and CEO of Nivaan Care.
A Pain Point India Can’t Ignore
Launched in 2023 by Nivesh Khandelwal and Vishwas Singh, Nivaan Care addresses a critical and often overlooked segment of Indian healthcare: chronic pain.
Their clinics currently operate in Delhi NCR, Mumbai, Jaipur, and Lucknow, offering a multidisciplinary approach combining:
- Pain physicians
- Physiotherapists
- Care coordinators
Treatments include Radiofrequency Ablation, Platelet-Rich Plasma (PRP) therapy, and other non-surgical interventions for persistent back, knee, and neck pain.
The startup claims to have delivered over 40,000 consultations and 5,000+ procedures to date.
Rhetorical hook: When nearly half of adults over 45 report joint pain, can India afford to treat it with just painkillers?
The Chronic Pain Opportunity
According to recent health data:
- 47% of Indians aged 45+ experience joint pain
- 31% suffer from persistent back pain
- Poor treatment access leads to irreversible damage and disability
Nivaan’s model fits into a growing demand for accessible, clinically-backed alternatives to long-term painkiller dependency.
Investor confidence is also building in the chronic care segment:
- FlexifyMe raised INR 20 Cr last year to scale online physiotherapy for back, neck, and shoulder pain
- Patch Up, based in Gurugram, plans to enter pain management through transdermal nutrient patches
According to Inc42’s Annual Indian Startup Trends Report 2025, India’s healthtech market is projected to grow at 39% CAGR, aiming to cross $37 Bn by 2030. Even as deal volume dropped from 78 in 2024 to 54 in 2025, quality investments in specialised care are seeing sustained momentum.
What Sets Nivaan Apart
Unlike generic physiotherapy or digital health platforms, Nivaan focuses on procedural and physician-led care, combining:
- Medical-grade diagnostics
- Minimally invasive interventions
- In-person and coordinated follow-up care
Its clinic-first strategy enables deeper trust, better outcomes, and potentially higher patient retention, especially in Tier-1 and Tier-2 cities where chronic pain is underserved yet rampant.
TL;DR:
Nivaan Care has raised $7 Mn in Series A funding led by Sorin Investments to expand its chronic pain clinic network and minimally invasive treatments. With over 40,000 consultations to date, the startup is riding the rising demand for non-surgical pain relief in India’s fast-growing healthtech space.
AI Summary:
- Nivaan Care raises $7 Mn from Sorin, W Health, Endiya, Rebright
- Focus: expanding pain clinics in cities like Bengaluru
- Offers non-surgical treatments like PRP and radiofrequency ablation
- Has delivered 40K+ consultations, 5K+ procedures
- Joins rising trend in chronic care startups amid healthtech sector growth
